| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604237 | International Journal of Cardiology | 2017 | 26 Pages |
Abstract
In this matched comparison of high surgical risk patients undergoing TAVI, the use of Evolut R was associated with a significant survival benefit at 1Â year compared with the CoreValve. This was driven by lower incidence of periprocedural complications and higher rates of correct anatomic positioning.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Cristina Giannini, Marco De Carlo, Corrado Tamburino, Federica Ettori, Azeem M. Latib, Francesco Bedogni, Giuseppe Bruschi, Patrizia Presbitero, Arnaldo Poli, Franco Fabbiocchi, Roberto Violini, Carlo Trani, Pietro Giudice, Marco Barbanti,